TrialAmerican journal of clinical oncology2015

Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung Cancer.

Robert M Sargis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.